Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
20.01. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.01.2025 | 488 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.01.2025ISIN NameAU000000CAI2 CALIDUS... ► Artikel lesen | |
14.01. | Nasdaq Stockholm AB: Delisting of Ziccum AB from Nasdaq First North Growth Market | 413 | GlobeNewswire | On January 10, 2025, Ziccum AB was declared bankrupt by Lund District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist the financial... ► Artikel lesen | |
10.01. | XFRA 7IZ: AUSSETZUNG/SUSPENSION | 354 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZICCUM AB 7IZ SE0011415595... ► Artikel lesen | |
10.01. | Ziccum AB: Ziccum AB (publ) files for bankruptcy | 306 | GlobeNewswire (Europe) | The board of directors of Ziccum AB (publ) ("Ziccum"or the "Company") has today, 10 January 2025, resolved to file for bankruptcy on behalf of the Company to manage the financial situation that has... ► Artikel lesen | |
25.11.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Ziccum AB (publ) | 362 | GlobeNewswire | With effect from November 26, 2024, the unit rights in Ziccum AB (publ) will be
traded on First North Growth Market. Trading will continue up until and
including December 05, 2024.
Instrument: Unit... ► Artikel lesen | |
20.11.24 | Ziccum AB: Ziccum publishes prospectus due to upcoming rights issue | 315 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
20.11.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 | 710 | Xetra Newsboard | Das Instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC ETF wird cum Kapitalmassnahme gehandelt am 20.11.2024 und ex Kapitalmassnahme am 21.11.2024 The instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC... ► Artikel lesen | |
ZICCUM Aktie jetzt für 0€ handeln | |||||
29.10.24 | Ziccum AB: Ziccum AB (publ) Interim report Q3 2024 | 177 | GlobeNewswire (Europe) | INTERIM REPORT Q3, 1 JULY - 30 SEPTEMBER 2024
Significant events after Q3 2024Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loanOn October 10, The Board... ► Artikel lesen | |
10.10.24 | Ziccum AB: Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loan | 215 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
30.08.24 | Ziccum AB: Ziccum AB (publ) Interim report Q2 2024 | 268 | GlobeNewswire (Europe) | INTERIM REPORT Q2, 1 JANUARY - 30 JUNE 2024
Significant events during Q2 2024Ziccum strengthens and streamlines business and finance functionsOn April 3, the company announced that it is reorganizing... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 45,570 | +3,19 % | Fresenius: Noch mehr Potenzial | Am Mittwochmorgen hat der Gesundheitskonzern Fresenius richtig gute Zahlen zum zweiten Quartal vorgelegt (DER AKTIONÄR berichtete) und die Umsatzprognose für das laufende Geschäftsjahr nach oben geschraubt.... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,480 | +0,45 % | dpa-AFX-Überblick: UNTERNEHMEN vom 07.08.2025 - 15.15 Uhr | ROUNDUP 2/Trotz Rekordgewinn: Allianz wagt keine höhere Prognose - Dax-Spitze MÜNCHEN - Der Versicherer Allianz traut sich trotz eines Rekords im ersten Halbjahr noch kein höheres Gewinnziel für... ► Artikel lesen | |
THERMO FISHER | 414,05 | -0,10 % | Plattform-Strategien krempeln Biotech-Markt um: BioNxt, Thermo Fisher Scientific, Evotec | Bei Biotech gilt längst nicht mehr das Prinzip alles oder nichts. Statt nur ein Produkt im Angebot zu haben, setzt sich bei der Entwicklung der Wirkstoffe von morgen die Plattform-Ökonomie durch. Was... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 66,80 | -0,18 % | Eurofins Sustainability Services Introduces Origin ID for Cotton Traceability - Offering Unparalleled Expertise and Support for Cotton Supply Chains | Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include Origin ID, a leading... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | Schock-News für Synlab Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
DAVITA | 114,45 | -0,56 % | Akebia outlines access to over 275,000 dialysis patients for Vafseo in Q4 as DaVita pilot launches | ||
DENTSPLY SIRONA | 11,840 | +0,04 % | Dentsply Sirona Posts Wider Loss In Q2 | WASHINGTON (dpa-AFX) - Dentsply Sirona posted a second quarter net loss of $45 million, or $0.22 per share, compared to a net loss of $4 million, or $0.02 per share, a year ago. Adjusted earnings... ► Artikel lesen | |
SMITH & NEPHEW | 15,900 | -0,13 % | SMITH & NEPHEW PLC - 6-K, Report of foreign issuer | ||
SONIC HEALTHCARE | 15,542 | -0,87 % | Dividendenbekanntmachungen (20.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,085 NZD 0,0453 EUR ABRDN UK SMALLER COMPANIES GROWTH TRUST ... GB0002959582 0,037 GBP 0... ► Artikel lesen | |
DIASORIN | 83,58 | +0,24 % | Dividendenbekanntmachungen (21.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFLAC INC US0010551028 0,58 USD 0,5141 EUR ARCHER DANIELS MIDLAND COMPANY US0394831020 0,51 USD 0,452 EUR ASSECO BUSINESS SOLUTIONS... ► Artikel lesen | |
PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
FULGENT GENETICS | 18,600 | -0,53 % | Fulgent Genetics: UBS stuft Aktie auf 'Kaufen' hoch und verweist auf Wachstumspotenzial | ||
PERSPECTIVE THERAPEUTICS | 3,160 | -3,07 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results | [212Pb]VMT-a-NET study update presented at the 2025 ASCO Annual Meeting, based on updated interim results from a Phase 1/2a study in neuroendocrine tumors. As of the April 30, 2025 data cut-off date:... ► Artikel lesen | |
IMPLANTICA | 6,130 | -5,84 % | Implantica finishes new multi-cavity production tool for RefluxStop to support manufacturing ramp-up in the U.S. pending FDA approval | VADUZ, Liechtenstein, Aug. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop®... ► Artikel lesen | |
OMNICELL | 26,600 | 0,00 % | Piper Sandler lowers Omnicell stock price target to $55 on tariff concerns |